Roundup Leads To Antibiotic Resistance In P. aeruginosa

Roundup Leads To Antibiotic Resistance In P. aeruginosa

Introduction

According to the researchers, glyphosate in Roundup may lead to hazardous germs growing resistant to existing antibiotics, resulting in serious damage or death.

The study comes amid ongoing worries about the long-term consequences of Roundup and glyphosate, which are both ingredients in the commonly used weedkiller and have previously been linked to an increased risk of non-Hodgkin's lymphoma.

The World Health Organization's International Agency for Research on Cancer (IARC) decided in 2015 to classify glyphosate in Roundup as a probable carcinogen, and the manufacturer has been accused of concealing information about the risk of non-Hodgkin's lymphoma for decades in order to avoid any negative impact on sales.

Tens of thousands of Roundup lawsuits have been filed in recent years as a result of Monsanto's failure to disclose the risk associated with their widely marketed weed killer, which uncovered internal documents highlighting how the company has covered up negative findings associated with glyphosate for decades, and manipulated study results involving the widely used weed killer.

While most recent research has focused on the cancer dangers of glyphosate, the key component in Roundup, there have long been worries about its impact on the environment, pollinators such as bees, and microbes.

Low-dose exposure to glyphosate acid (GLY) and glyphosate-based herbicides (GBHs), such as Roundup, appears to boost the antibiotic resistance qualities of Pseudomonas aeruginosa, which can cause severe infections and pneumonia, according to researchers from Hungary.

The gram-negative bacterium Pseudomonas aeruginosa (P. aeruginosa) is commonly found in soil and water. However, it is frequently transferred in hospital settings via contaminated surfaces, people, and equipment, and it can frequently acquire antibiotic resistance.

P. aeruginosa infections can be fatal, causing pneumonia, fevers and chills, breathing difficulties, chest discomfort, tiredness, and coughing. It has a mortality rate that ranges from 18% to 61%.